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Abstract
Mitochondrial dysfunction, caspase activation and caspase-dependent DNA fragmentation are involved in cell damage in
many tissues. However, differentiated cardiomyocytes repress the expression of the canonical apoptotic pathway and their
death during ischemia is caspase-independent. The atypical BH3-only protein Bnip3 is involved in the process leading to
caspase-independent DNA fragmentation in cardiomyocytes. However, the pathway by which DNA degradation ensues
following Bnip3 activation is not resolved. To identify the mechanism involved, we analyzed the interdependence of Bnip3,
Nix and EndoG in mitochondrial damage and DNA fragmentation during experimental ischemia in neonatal rat ventricular
cardiomyocytes. Our results show that the expression of EndoG and Bnip3 increases in the heart throughout development,
while the caspase-dependent machinery is silenced. TUNEL-positive DNA damage, which depends on caspase activity in
other cells, is caspase-independent in ischemic cardiomyocytes and ischemia-induced DNA high and low molecular weight
fragmentation is blocked by repressing EndoG expression. Ischemia-induced EndoG translocation and DNA degradation are
prevented by silencing the expression of Bnip3, but not Nix, or by overexpressing Bcl-xL. These data establish a link between
Bnip3 and EndoG-dependent, TUNEL-positive, DNA fragmentation in ischemic cardiomyocytes in the absence of caspases,
defining an alternative cell death pathway in postmitotic cells.
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Introduction
Caspase activation has been involved in the pathophysiology of
the cell death processes in terminally differentiated cells including
neurons and cardiomyocytes. However, recent results show that
proteins in the canonical apoptotic signaling pathway are not
detectable in postmitotic cells [1,2] and the role of caspases in
some diseases such as ischemia remains controversial [3,4][. In this
context, elucidation of the mechanisms mediating caspase-
independent cell damage could be relevant for understanding
alternative pathways to caspase-dependent cell death.
Activation of the apoptotic mitochondrial pathway in many cell
types includes interaction of a BH3-only protein with components
of the outer mitochondrial membrane (OMM), mitochondrial
dysfunction, apoptosome assembly, caspase activation and DNA
processing by Caspase-Activated DNAse (CAD/DFF40) [5].
Bnip3 and Nix form an atypical subfamily of the BH3-only
proapoptotic proteins related to Bcl-2 [6]. Their expression was
described to be activated by hypoxia, involving Hypoxia Inducible
Factor-1 (HIF-1)-dependent transcription [7,8]. Surprisingly,
Bnip3 was shown to be abundant in the adult heart in normoxia
[9]. Bnip3 has been involved in hypoxia/acidosis-induced DNA
damage in cardiomyocytes [10]. Increased resistance to hypoxia-
induced cell death of pancreatic and colorectal cancer cells
deficient for Bnip3 further supports the relevance of Bnip3 during
hypoxia-induced death [11,12]. Integration of Bnip3 in the OMM
leads to mitochondrial damage [13–15], including opening of the
mitochondrial permeability transition pore [16]. Deficiency in
Bnip3 in vivo has been shown to improve heart function after
ischemia/reperfusion although the mechanisms involved are not
clear [17]. Finally, Bnip3 induces caspase-independent nuclear
DNA degradation [10,16]. This fact has been described as
surprising [16], unusual [7,10], interesting [18] and paradoxical
[19] in cardiomyocytes but remains unexplored.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17998Endonuclease-G (EndoG) is a mitochondrial protein with
DNase/RNase activity [20], which has been recently shown to
be involved in apoptotic DNA degradation [21,22]. EndoG
apoptotic activity requires its release from mitochondria, and
occurs in the absence of caspase activation [21]. Although Li and
Wang demonstrated that EndoG activity is relevant only in
caspase-independent cell damage, caspase-dependent paradigms
were used for the phenotypic characterization of EndoG-deficient
mice, which were the basis for discarding a relevant role of EndoG
in apoptosis [23,24]. We have recently reported that EndoG is
important for DNA degradation in cardiomyocytes, where the
caspase-dependent pathway is repressed during differentiation and
is not re-expressed during experimental ischemia [25]. However,
the pathway leading to EndoG-dependent DNA damage remains
debated [26].
We hypothesized that EndoG could be the executor of caspase-
independent DNA processing in the Bnip3-mediated cardiomyo-
cyte death pathway. The results presented here support this
hypothesis and help to clarify other functional aspects dealing with
ischemia-induced cell death, such as the role of endogenous Bnip3
in triggering translocation of mitochondrial apoptotic regulators in
the absence of caspase activity, and the caspase-independent
nature of the TUNEL labeling in damaged cardiomyocytes.
Results
EndoG and Bnip3 are expressed during development and
are abundant in the adult heart, contrary to the caspase-
dependent protein network
We have previously shown that many key regulators of the
caspase-dependent cell death signaling cascade are abundant in
the embryonic heart but their expression is downregulated during
development and these proteins are not re-expressed during
experimental ischemia or ischemia-reoxygenation in vitro [2]. Our
previous results and data presented here show that experimental
ischemia does not induce caspase activation in primary rat
cardiomyocytes and that ischemia-induced DNA damage in these
cells depends on EndoG (Figures S1 and S2 and ref. [25]). Here
we extend the knowledge about EndoG expression. We produced
an EndoG-specific antibody (AntibodyBcn, BCN4778) because in
our hands the majority of commercial antibodies detected an
unspecific band (Figure S3). Our data show that EndoG is most
abundant in the heart, skeletal muscle and liver in the adult rat
(Figure 1a). In the cardiac ventricle, EndoG expression increases
during heart development contrary to Apaf-1, Caspase-3 and
CAD, which are key regulators of the caspase-dependent death
pathway (Figure 1b). Bnip3 protein has been shown to be
abundant only during hypoxia in several cell types [8,12] but
recently it has been reported to be expressed in the adult heart in
normoxia [9]. Using a different anti-Bnip3 antibody (Cell
Signaling, 3769), we have found that Bnip3 protein is mainly
expressed in the heart, brain and skeletal muscle in the adult rat
(Figure 1a) and its abundance increases in the heart during
development (Figure 1b) and during hypoxia in neonatal myocytes
(Figure 1c), contrary to the genes regulating the caspase-dependent
pathway that are highly expressed in other cell types and are not
re-expressed in myocytes during ischemia (Figure 1c). Anti-
apoptotic Bcl-xL is the only Bcl-2-related protein abundant in
the adult heart (ref. [2] and Figure 1b). Thus, our results suggest
that in the differentiated myocardium and in ischemic myocytes
EndoG, Bnip3 and Bcl-xL are abundant whereas the expression of
the caspase-dependent cell death machinery is silenced and is not
re-expressed during ischemia.
Bnip3 and EndoG trigger caspase-independent, TUNEL
positive DNA fragmentation in ischemic cardiomyocytes,
which is a caspase-independent paradigm
Bnip3 has been involved in chromatin condensation [13], and
in ischemia-induced cardiomyocyte DNA low molecular weight
(LMW) fragmentation [10]. Although the Bnip3-related protein
Nix also has a pro-apoptotic role [6,17] and its expression is up-
regulated during hypoxia in several cell lines [7,8], its involvement
in hypoxia-induced cell death is less clear [27]. We developed
lentiviral-based small hairpin RNA interference systems (shRNA)
for silencing efficiently Bnip3 and Nix expression in primary
postnatal cardiomyocytes (Figure S2, Figure 2, a and b). Silencing
Bnip3 expression, but not that of Nix, blunted high molecular
weight (HMW) and LMW DNA degradation during experimental
ischemia (Figure 2c). The effect of Bnip3 silencing on DNA
integrity during ischemia was similar to this of repressing EndoG
(Figure 2c, right panel). Both EndoG and Bnip3, but not Nix, were
essential for inducing TUNEL-positive DNA fragmentation in
experimental ischemia, which did not involve caspase activity
(Figure 2d). Thus, caspase-independent EndoG activity was
involved in the production of DNA -3’OH single strand nicks
detected by the TUNEL assay, which has been routinely used as a
measure of Caspase-Associated DNase (CAD) activity and, hence,
caspase activation in cardiomyocytes. Survival of ischemic
cardiomyocytes, measured in control (100% survival) and ischemia
by the trypan blue exclusion assay, was not affected by silencing
Bnip3 expression (67.069.74% vs. 62.768.13% scrambled-
transduced vs. shBnip3-transduced cardiomyocytes, n=3). These
data improve former knowledge by showing that Bnip3, but not
Nix, is involved in ischemia-induced DNA high as well as low
molecular weight fragmentation, and that ischemic DNA damage
detected by the TUNEL assay proceeds in the absence of caspase
activation in cardiomyocytes.
BNIP3 controls EndoG release from cardiac mitochondria
and Bcl-xL can block EndoG translocation and caspase-
independent DNA damage
Experimental ischemia induced the release of EndoG-FLAG
from cardiomyocyte mitochondria as shown by the diffuse pattern
of expression in ischemic cardiomyocytes treated with 12 hours of
experimental ischemia and fixed with 4% PFA, where staining also
included cell nuclei (Figure 3a and b). Silencing Bnip3 expression
by shRNA contributed to maintain EndoG-FLAG normal
localization, excluding the nucleus (Figure 3a and b). Western
blot analysis of EndoG-FLAG expression in cytosolic extracts of
cardiomyocytes in the same conditions confirmed that Bnip3
silencing prevented EndoG-FLAG release from mitochondria
(Figure 3c).
Bcl-xL overexpression has been shown to protect cardiac
mitochondria during ischemia and to reduce DNA fragmentation
detected by TUNEL in a Langendorf perfusion model [28]. Thus,
we assessed whether Bcl-xL, which is expressed in the differenti-
ated myocardium (as shown in Figure 1b), was efficient in blocking
EndoG nuclease activity. Bcl-xL overexpression was induced in
cultured cardiomyocytes before ischemia (Figure 4a) and DNA
integrity was analyzed by agarose gel electrophoresis in control
and ischemic conditions. The results suggest that Bcl-xL
overexpression blocks DNA fragmentation during ischemia for
6 hours (Figure 4b) in the absence of detectable executioner
caspase activation (Figure S1). In order to know whether Bcl-xL
prevented EndoG translocation during ischemia, EndoG expres-
sion was analyzed by immunofluorescence in control and ischemic
cardiomyocyte cultures, which were also overexpressing EndoG-
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even when released from mitochondria. In empty virus-transduced
ischemic cardiomyocytes the pattern of EndoG-FLAG expression
was diffuse (Figure 5a), suggesting translocation, which was
significantly prevented in cardiomyocytes overexpressing Bcl-xL
(Figure 5a and b). Western blot analysis of EndoG-FLAG
expression in cytosolic extracts of cardiomyocytes in the same
conditions confirmed that Bcl-xL overexpression prevented
EndoG-FLAG release from mitochondria (Figure 5c). To
complete these results, we fixed other cultures from the same
experiment with methanol. This procedure allowed co-staining of
EndoG-FLAG and the mitochondrial marker Hsp60, demonstrat-
Figure 1. EndoG and Bnip3 are most highly expressed in rat heart, and are located to cardiac myocytes thorough development and
during ischemia. a) Western blot analysis of EndoG, using a new anti-EndoG antibody (AntibodyBcn, BCN4778) and Bnip3 protein expression in
total protein extracts from different adult rat tissues. EndoG is detected as a single band (,27 kDa) and Bnip3 is detected as a group of bands around
the 26 kDa mark (asterisk), in agreement with the information provided by the manufacturer. Both proteins are expressed mainly in the heart and
skeletal muscle. Detection of EndoG and Bnip3 was performed in two different sets of independent samples with similar results. b) Western blot
detection of EndoG, Bnip3 and proteins involved in caspase-dependent cell death in total protein extracts of ventricles from rats of different ages
ranging from embryonic day 20 to adulthood. A representative image is shown from three independent experiments. c) Neonatal cardiomyocytes
were treated with ischemia and the abundance of EndoG, Bnip3 and proteins involved in the caspase-dependent pathway was analyzed by Western
blot in extracts obtained at different time points. Primary heart fibroblasts and neonatal liver samples were added for comparison. A representative
image is shown from three independent experiments.
doi:10.1371/journal.pone.0017998.g001
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PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17998Figure 2. Bnip3 and EndoG trigger caspase-independent TUNEL positive DNA fragmentation in ischemic cardiomyocytes. a)
Efficiency of Bnip3 and Nix shRNA-mediated knock down was analyzed by RT-PCR and / or Western blot from postnatal cardiomyocyte total RNA or
protein extracted at day 4 post-transduction. b) Efficiency of EndoG shRNA-mediated knock down and specificity of the new anti-EndoG antibody was
analyzed by Western blot in the same conditions than in a. c) Agarose gel electrophoresis of DNA extracts of cardiomyocytes cultured in normal
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S4). However, in ischemic cardiomyocytes, the FLAG staining was
lost in absence of Bcl-xL overexpression, probably due to wash out
of the released EndoG-FLAG during the immunofluorescence
procedure because methanol dissolves membrane lipids. These
results demonstrate that EndoG-FLAG localizes to mitochondria
and is released during ischemia, and that Bcl-xL overexpression
can block this event by protecting mitochondrial integrity. Taken
together, our findings showed that Bcl-xL efficiently blocked
translocation of overexpressed EndoG and prevented caspase-
independent DNA damage in ischemic cardiomyocytes.
Discussion
The events leading to EndoG-mediated DNA fragmentation
and the pathway mediating Bnip3-induced DNA damage are not
well understood. Here we show that EndoG and Bnip3 form a
protein network involved in caspase-independent DNA fragmen-
tation in differentiated cardiomyocytes during ischemia. Our
results suggest that ischemia-induced TUNEL-positive DNA
damage in cardiomyocytes in vitro is triggered by EndoG and
depends on EndoG release from mitochondria induced by Bnip3
in a way that can be partially blocked by Bcl-xL, without the
involvement of caspases.
The actual relevance of EndoG activity is still a mater of
debate, with papers supporting it in yeast [29], cardiomyocytes
[25] and hepatocytes [30] and papers suggesting a minor role of
this nuclease in other cell types [23,24]. Our results complement
the knowledge about the relevance of EndoG by showing that
EndoG activity depends on Bnip3 without the involvement of
caspases in cardiomyocytes. Indeed, EndoG was initially reported
to degrade nuclear DNA when caspases were inhibited [21]
and has been evidenced in caspase-independent paradigms
[25,29,30]. Interestingly, the experiments discarding a relevant
role of EndoG where performed in caspase-dependent paradigms
such as splenocytes [23] and mouse embryonic fibroblasts [24],
were caspases and CAD/DFF40 play a major role in DNA
degradation.
There is also a certain degree of disagreement about the
contribution of the canonical caspase-dependent apoptotic path-
way to ischemia-induced cell death, which was initially suggested
in cardiomyocytes by Tanaka and co-workers [31]. The extrinsic,
death receptor-dependent, apoptotic cascade ([32], and others)
and the mitochondria-dependent pathway of apoptosis [33] have
been suggested to contribute to cardiomyocyte death during
ischemia or ischemia/reperfusion. However, simultaneous reports
showed that myocyte damage and death in these and other
contexts were unrelated to caspases [3,4,10,25,34]. The lack of
caspase activity in ischemic cardiomyocytes is in agreement with
previous findings showing that expression of the apoptotic genes is
silenced during cardiomyocyte differentiation [2,25]. Using
different approaches, it has been shown that Bcl-2 and Bcl-xL
blunt ischemia-induced cardiomyocyte damage [28,35,36], also
suggesting the involvement of the caspase-dependent pathway
triggered by Cytochrome c translocation. The use of the TUNEL
assay and agarose-gel electrophoresis to assess DNA fragmentation
as reliable methods for detecting apoptotic myocytes in human
samples contributed to the knowledge about the role of cell death
in heart failure but unwittingly biased the interpretation of the
mechanisms involved in this event [37,38] and others.
Although many excellent works demonstrated the essential role
of Bnip3 in DNA damage in myocytes and other cell types
[7,16,18], the nuclease executing Bnip3-dependent DNA damage
in cardiomyocytes has not been identified so far. Here we show
that endogenous Bnip3 induces EndoG release and caspase-
independent EndoG-dependent DNA fragmentation, supporting
that EndoG executes DNA damage triggered by Bnip3. Our
results are in agreement with two recent reports showing the
association between Bnip3 and EndoG activity in cortical neurons
during long exposure to hypoxia and in hippocampal neurons
during reoxygenation although in those cells the process appeared
to be much slower than in cardiomyocytes [39,40]. We also extend
the knowledge about the role of Bnip3 in DNA damage by
showing for the first time that high molecular weight DNA
fragmentation also depends on Bnip3 activity. In addition,
although cell damage induced by Bnip3 depends on Bax and
Bak activation and induce caspase activation in caspase-dependent
cellular models such as embryonic fibroblasts (MEF) and HL-1
immortalized embryonic atrial myocytes [41], our results give
support to a role of Bnip3 unrelated to caspases in differentiated
cardiomyocytes as previously shown by others [10] and also
suggest a caspase-independent mechanism for the known protec-
tive role of overexpressed Bcl-xL in the heart [28]. The shorter
time of protection from DNA damage achieved by Bcl-xL
overexpression compared to Bnip3 silencing in our paradigm
could be explained by Bnip3 increased expression during ischemia
eventually overcoming Bcl-xL-dependent blockade of EndoG
release. Furthermore, the link between TUNEL-positive DNA
fragmentation and caspase activity, which is true for other cellular
models and that has been assumed for cardiomyocytes, was
questioned previously by investigations performed in tissue
samples [4,42]. Our data demonstrate that the TUNEL signal is
produced by the activity of EndoG without the contribution of
caspases in ischemic cardiomyocytes.
In summary, our results provide evidence that 1) EndoG and
Bnip3 are expressed abundantly in the differentiated myocardi-
um compared to the embryo, in contrast to the caspase-
dependent machinery, 2) EndoG is the link between Bnip3-
mediated mitochondrial dysfunction and DNA degradation
during ischemia in cardiomyocytes, assembling a protein
network unrelated to caspases in postmitotic cells, 3) TUNEL
labeling is due to EndoG and is unrelated to caspase activity in
ischemic myocytes in vitro and 4) Bcl-xL can prevent transiently
caspase-independent DNA fragmentation by blocking EndoG
translocation from mitochondria in the presence of Bnip3. All
this agrees with a type of caspase-independent cell damage that
can take place after the global expression silencing of genes of
the caspase-dependent signaling cascade in postmitotic cells such
as cardiomyocytes.
conditions or after 16 hours of experimental ischemia. Cardiomyocytes were transduced 5 days before ischemia with constructs for the silencing of
Bnip3, Nix or EndoG genes. A sample from scrambled-transduced cardiomyocytes treated with ischemia in the presence of 100 mM pan-caspase
inhibitor z-VAD-fmk was added to show that DNA fragmentation was caspase-independent in this paradigm. HMWF: High molecular weight DNA
fragmentation detected by pulse-field electrophoresis as reported in the Materials and Methods section. LMWF: Low molecular weight DNA
fragmentation detected by conventional agarose gel electrophoresis from the same cell extracts. d) DNA integrity was measured by the TUNEL assay
following the same treatments as in B. TUNEL staining was detected as a red fluorescent signal, which, in combination with blue Hoechst nuclear
staining produced a pink hue. Gel images are representative of three independent experiments. TUNEL-positive nuclei (pink) are expressed as mean
vs. total nuclei (blue+pink) from three independent experiments counted in duplicates. Scr: scrambled. Error bars are s.e.m.
doi:10.1371/journal.pone.0017998.g002
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Ethic statement
The investigation with experimental animals conforms to the
Guide for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No. 85-23,
revised 1996) and the National Guidelines for the regulation of the
use of experimental laboratory animals from the Generalitat de
Catalunya and the Government of Spain (article 33.a 214/1997)
and was evaluated and approved by the Experimental Animal
Ethic Committee of the University of Lleida (CEEA) (Permit
numbers for dissection of adult rat tissues: CEEA 04-03/08 and
Figure 3. BNIP3 controls EndoG release from cardiac mitochondria during ischemia. a) Immunofluorescence of EndoG-FLAG in
overexpressing neonatal cardiomyocytes cultured in control (control) and ischemic (ischemia) conditions for 12 hours. Bnip3i: cardiomyocytes with
silenced expression of Bnip3 by shRNA. Scr: scrambled. Arrows: cardiomyocytes where EndoG-FLAG expression includes the nucleus. A merged image
including Hoechst nuclear staining is included for ischemic cardiomyocytes to localize the nuclei. Arrowheads: ischemic cardiomyocytes where
EndoG-FLAG expression excludes the nucleus. Similar results were obtained in three independent experiments. b) Quantification of the experiments
described in a). The graph shows the percentage of cardiomyocytes with diffuse pattern of the EndoG-FLAG staining in control and ischemic cultures
of scrambled-transduced cells (scr) and cells transduced with viruses for Bnip3 silencing (Bnip3), counted in three independent experiments. Error
bars are s.e.m. c) Endogenous EndoG release was assessed by Western Blot in cytosolic extracts from control cardiomyocytes (scr) and
cardiomyocytes expressing low levels of Bnip3 (achieved by shRNA-driven knockdown) in standard and ischemic conditions. Lactate dehydrogenase
(LDH) expression was checked as a cytosolic marker and Hsp60 expression was assessed as a mitochondrial membrane marker. The image shows
representative results from 3 independent experiments.
doi:10.1371/journal.pone.0017998.g003
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obtain tissues and primary cell culture of cardiomyocytes: CEEA
06-03/08).
Tissues, cardiomyocyte isolation, cell culture and
ischemia treatment
Adult three-month-old male Sprague Dawley rats were
sacrificed by exposure to carbon dioxide and tissues were dissected
as previously described [2]. P0–P5 Sprague–Dawley rat neonates
were sacrificed, following the above Guide approved by the
CEEA, by decapitation and cardiomyocytes were obtained from
the hearts as described elsewhere [43]. Purity of cardiomyocyte
cultures was routinely checked by immunocytochemistry with a
cardiac sarcomeric a-actinin antibody (clone EA-53, SIGMA,
Saint Louis, MO, USA) and was found to be higher than 90%
after 24–48 hours in vitro. Experimental ischemia of the cultured
cells was achieved by culturing cells in Tyrode’s solution (NaCl
137 mM, KCl 2.7 mM, Na2HPO4 8 mM, KH2PO4 1.5 mM,
CaCl2 0.9 mM and 0.5 mM, initial pH: 7.2) inside a hypoxic
chamber (Ruskin InVivo400, Cultek) continuously monitored for
achieving 0.2% O2 and 5% CO2. Pan-caspase inhibitor Z-Val-
Ala-Asp(OMe)-CH2F (z-VAD-fmk) (Calbiochem) was added at
100 mM final dilution where indicated.
Lentiviral vectors for gene silencing and overexpression
EndoG small hairpin RNA interference (shRNA) construct has
been described elsewhere [25]. The Bnip3 and Nix shRNA vectors
were obtained following the same protocol as for EndoG, using the
sequences 59-GATACCAACAGAGCTGAAATA-39 and 59-
GAAGACGGGCAAATAATGT-39, respectively. Viruses were
prepared and tittered as described [25]. Treatment of cardiomy-
ocytes was started always five days after transduction, i.e. after
seeding. RT-PCR primers for detecting Bnip3 were Forward:
59-GAATCTGGACGAAGCAGCTC-39 and Reverse: 59-AA-
CATTTTCTGGCCGACTTG-39 with an expected amplicon
size of 230 bp, and Nix primers Forward: 59-CAATGGAGA-
CATGGAGAAGAT-39 and Reverse 59-ATGTTTTCGGGTC-
TACTGGA-39 produced a 252 bp amplicon. Unr expression was
detected to monitor loading as previously reported [25]. All
experiments carried out with transduced cardiomyocytes were
repeated at least four times. For EndoG-FLAG overexpression we
obtained the EndoG-FLAG fragment from the pcDNA3. EndoG-
FLAG construct [25] and subcloned it into the pEIGW vector for
lentiviral transduction. The open reading frame of human Bcl-xL
was amplified from retro-transcribed 293T human cell line total
mRNA, was subcloned into the pcDNA3 vector (Invitrogen),
sequence-verified and then subcloned into the pEIGW vector for
lentiviral-driven overexpression. Viral particles where obtained as
previously described [2]. Simultaneous overexpression of EndoG-
FLAG and Bcl-xL was achieved by adding equal volumes of viral
stocks for each gene at 6 hours in vitro, washing and replacing with
the required medium 24 hours later. Expression was assessed by
Western Blot prior to experimental ischemia, which was
performed three days after infection.
Total and cytosolic protein extraction, Western blot and
Immunofluorescence detection
Whole cell lysates and cytosolic protein extracts were obtained
and processed as described [25]. Equal amounts of protein were
electrophoresed by SDS-PAGE, transferred to PVDF membranes
(Amersham), and probed with specific antibodies. Antibodies used
were against Apaf-1 (Alexis, ALX-804-349-C100), Bcl-xL (BD
Figure 4. Bcl-xL can block caspase-independent DNA damage in ischemic cardiomyocytes. a) Assessing overexpression of Bcl-xL in normal
cardiomyocytes and simultaneous EndoG-FLAG overexpression. b) Agarose gel electrophoresis of DNA extracts of cardiomyocytes cultured in normal
conditions or after 6 hours of experimental ischemia. Cardiomyocytes were transduced 5 days before ischemia with lentivirus for overexpression of
Bcl-xL or empty viruses. HMWF and LMWF: high and low molecular weight DNA fragmentation, respectively. Similar results were obtained in three
independent assays.
doi:10.1371/journal.pone.0017998.g004
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DFF40 (Millipore AB16926), Caspase-3 (Cell Signaling, 9665),
Cytochrome c (Cell Signaling, 4272), EndoG (SIGMA, E5654;
ProSci, PSC-3035), FLAG (SIGMA, A2220), Hsp60 (BD Trans-
duction), Prohibitin (NeoMarkers, 292P501F) and all secondary
antibodies were from Invitrogen. Commercial antibodies against
EndoG were unspecific (band size not matching EndoG size and
signal not reduced in cells with efficient specific knockdown of
EndoG), we prepared a polyclonal antibody against a peptide from
the C-terminal region of EndoG (Antibody Barcelona, BCN4778)
useful for Western blot detection but not for immunofluorescence,
which was performed after fixing cells either with 4% parafor-
maldehyde (PFA) for 30 minutes or 100% methanol for 2 minutes,
as previously described [25].
DNA Integrity Assays
Cells were pelleted at the end of each treatment and frozen at
280uC. Pellets from the same experiment were processed at once
and processed as previously described [25]. For analysis of DNA
high molecular weight degradation, the blocks were then laid into
wells of a 1% agarose, 0.56 TBE gel (CHEF grade, SIGMA-
Aldrich). Pulse field electrophoresis was performed as previously
described [25] in a CHEF DR-II system (BioRad, Hercules, CA,
USA) set to the following protocol: run time, 14 h; switch time
from 5 to 50 s; voltage gradient, 6 V/cm. For DNA low molecular
weight fragmentation, the first volume of DNA extraction
obtained after 24 hours of incubation of the agarose blocks [25]
was mixed with 100% ethanol at 220uC overnight, centrifuged,
washed in 70% ethanol, eluted in TE buffer and electrophoresed
in conventional 1.5% agarose gels. Gels were stained with SYBR
Safe (Molecular Probes-Invitrogen), visualized by UV exposure
and recorded with a Kodak DC290 digital camera. DNA integrity
was also assessed by TUNEL staining of cardiomyocyte cultures
fixed with 4% PFA after the treatments specified in the figure
legend and was performed with the ApopTag kit (CHEMICON)
following manufacturer’s instructions. Analysis of DNA damage
was also performed in cardiomyocyte cultures and cultures of
293T cells (positive control) treated with ischemia in the presence
Figure 5. Bcl-xL blocks EndoG translocation in ischemic cardiomyocytes. a) Immunofluorescence of EndoG-FLAG in control and ischemic
(6 hours) cardiomyocytes transduced previously with viruses inducing EndoG-FLAG overexpression and empty viral particles (Ø) or particles inducing
Bcl-xL overexpression. Cells were fixed with paraformaldehyde. This procedure allows detection of EndoG-FLAG, even when it is released from
mitochondria, but not the mitochondrial marker Hsp60 (see the results section and Supplementary Figure 3). b) Quantification of the experiments
described in a). The graph shows the percentage of cardiomyocytes with diffuse pattern of the EndoG-FLAG staining in control and ischemic cultures
of empty virus-transduced cells (Ø) and cells transduced with viruses for Bcl-xL overexpression (Bcl-xL), counted in three independent experiments.
Error bars are s.e.m. c) EndoG-FLAG release was assessed by Western Blot in cytosolic extracts from control cardiomyocytes (transduced with EndoG-
FLAG and empty viruses) and cardiomyocytes overexpressing Bcl-xL (transduced with EndoG-FLAG and Bcl-xL viruses), in standard and ischemic
conditions. Expression of Bcl-xL was assessed to confirm its increased expression in cardiomyocytes transduced with Bcl-xL. Lactate dehydrogenase
(LDH) expression was checked as a cytosolic marker and Hsp60 expression was assessed as a mitochondrial membrane marker. The image shows
representative results from 3 independent experiments.
doi:10.1371/journal.pone.0017998.g005
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DMSO to assess potential effects of the vehicle (Figure S5).
Supporting Information
Figure S1 Caspase 3-like enzymatic activity during
ischemia in cardiomyocytes and HEK293T cells. Execu-
tioner caspase activity in cultured primary rat neonatal cardio-
myocytes exposed to experimental ischemia was measured by
detecting the cleavage of the substrate DEVD.AFC as previously
reported (25). In brief, the medium of cardiomyocyte cultures was
replaced with Tyrode’s solution (see Materials and Methods
section) and the plates were placed in an hypoxic chamber set at
0.1% Oxygen and 5% CO2 pressures for 0, 4, 6, 12 or 24 hours.
The 293T cell line used for preparing the viruses, which express
standard amounts of all the regulators of caspase-dependent cell
death, was used as a positive control for the assay. Protein
extraction from duplicate plates was performed and the protein
concentration was measured by the Lowry assay. Equal amounts
of protein (25 mg) were incubated at 37uC with the substrate at
50 mM in 96-well plates. Fluorescence produced by cleavage of the
substrate was detected with a Bio-tek FL 600 fluorometer (Izasa).
Data obtained for different experimental conditions were com-
pared within the linear phase of absorbance increase. Data are
mean of three independent experiments performed in duplicates.
Bars are s.e.m. *, p,0.01 vs. time 0.
(PDF)
Figure S2 Sequence position of two different shRNA
oligonucleotides for EndoG and Bnip3 knockdown and
their effects on ischemia-induced DNAdamage in car-
diomyocytes. a) Two different shRNA sequences were chosen
for EndoG (Bahi et al., 2006) and Bnip3 gene knockdown and
functionally tested in ischemia-induced DNA damage in cardio-
myocytes as described in the Material and Methods section. b)
Both shRNA constructs for each gene were equally effective in
protecting DNA integrity. Due to the similar effects of both
lentiviruses for each gene on DNA integrity protection, only
shRNA-1 for each gene was used to conduct the experiments
presented in the article.
(PDF)
Figure S3 Assessment of the specificity of commercial
and in-house prepared anti-EndoG antibodies. For each
Western blot, 40 mg of total protein was loaded of neonatal
cardiomyocytes transduced with empty viruses, viruses for shRNA-
mediated EndoG silencing (shRNA) or viruses for EndoG-FLAG
overexpression as well as several cell lines: SH-SY5Y human
neuroblastoma, PC12 rat pheochromocytoma, HEK293 human
embryonic kidney, HeLa human carcinoma and 3T3 mouse
fibroblasts. Antibodies from SIGMA and ProSci (corresponding to
the same original product) were used following manufacturer’s
instructions. In-house produced antibody (AntibodyBcn BCN4778)
wasused at1:3000 dilution.Membranesweredevelopedwith Super
Signal reagent and images were obtained after exposure of the
membranes to Fuji Super RX film. The experiment was repeated
several times with similar results. The orange square indicates the
region of the EndoG peptide used to immunize rabbits for each
antibody.
(PDF)
Figure S4 Effect of Bcl-xL overexpression in ischemia-
induced translocation of EndoG-FLAG. Immunofluores-
cence of EndoG-FLAG in control and ischemic (6 hours)
cardiomyocytes transduced 3 days before with viruses inducing
EndoG-FLAG overexpression or empty viral particles (Ø) in
presence or absence of particles inducing Bcl-xL overexpression.
Cells were fixed with methanol as described in the Materials and
Methods section. This procedure does not allow detection of
EndoG-FLAG when released from mitochondria, because of
washing out during the procedure, but allows simultaneous
detection of the mitochondrial marker Hsp60 and is complemen-
tary to the results shown in Figure 5A.
(PDF)
Figure S5 Ischemia-induced DNA damage in cardiomy-
ocytes and 293T cells in presence of 100 mM zVAD in
DMSO or DMSO alone. Cultures of neonatal rat cardiomy-
ocytes (0.8610
6 cells) or confluent cultures of 293T (1610
6 cells)
were incubated in Tyrode’s solution at 0.1% oxygen in a hypoxic
chamber during 12 hours in the presence of zVAD-fmk 100 mM
(diluted in DMSO) or equal volume of DMSO without caspase
inhibitor. Cells were processed as detailed in Materials and
Methods section and low molecular weight fragmentation (ladder)
was assessed in 1.5% agarose gels. Experiments were repeated
twice with identical results.
(PDF)
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